Tocilizumab for juvenile idiopathic arthritis: a single-center case series

Tocilizumab for juvenile idiopathic arthritis: a single-center case series

ABSTRACT BACKGROUND: Juvenile idiopathic arthritis (JIA) is the commonest chronic rheumatic disease among children. When not treated effectively, JIA can lead to functional disability, due to joint damage, along with long-term morbidities. OBJECTIVES: To describe the use of tocilizumab therapy f...

Full description

Bibliographic Details
Main Authors: Fatma Yazılıtaş, Semanur Özdel, Doğan Şimşek, Özlem Aydoğ, Evrim Kargın Çakıcı, Gökçe Gür Can, Tülin Güngör, Mehmet Bülbül
Format: Article
Language:English
Published: Associação Paulista de Medicina 2020-03-01
Series:São Paulo Medical Journal
Subjects:
Child
Juvenile idiopathic arthritis
Tocilizumab
Childhood
Chronic arthritis
Interleukin-6 inhibitors
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802019000600517&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802019000600517&tlng=en

Similar Items